Checkmate 77T: Perioperative chemoimmunotherapy outperforms in early-stage NSCLC

被引：0

作者：

Brazel, Danielle ^{[1
]}

Nagasaka, Misako ^{[2
,3
]}

机构：

[1] Scripps Green Hosp, Scripps Clin, Dept Hematol Oncol, 10166 N Torrey Pines Rd, La Jolla, CA 92037 USA

[2] Univ Calif Orange, Chao Family Canc Ctr, Irvine Sch Med, 101 City Dr, Orange, CA 92868 USA

[3] St Marianna Univ, Sch Med, Kawasaki, Japan

来源：

MED | 2024年 / 5卷 / 08期

关键词：

D O I：

10.1016/j.medj.2024.06.012

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Approximately 1 in 4 patients with NSCLC present with resectable disease. Although surgery is potentially curative, 30%-50% of patients relapse. Studies have shown that neoadjuvant, adjuvant, and perioperative chemoimmunotherapy improve outcomes. The Checkmate 77T trial explored if perioperative platinum-based chemotherapy plus nivolumab, surgical resection, then adjuvant nivolumab further improved outcomes including EFS.

引用

页码：852 / 855

页数：4

共 50 条

[41] Biomarker testing in early-stage NSCLC: Results from the MYLUNG Consortium
Evangelist, Makenzi Colleen
Butrynski, James Edward
Paschold, John C.
Ward, Patrick J.
Waterhouse, David Michael
Spira, Alexander I.
Ali, Kashif
Hakimian, David
Jotte, Robert M.
Larson, Timothy
Meshad, Michael W.
Owera, Rami
Richards, Donald A.
Neubauer, Marcus A.
Robert, Nicholas J.
Yori, Jennifer L.
Pant, Manoj
Coleman, Robert L.
Spigel, David R.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[42] Tumor response and toxicity in neoadjuvant erlotinib in early-stage NSCLC patients
Klomp, H. M.
Schaake, E.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[43] Immune characteristics associated with lymph node metastasis in early-stage NSCLC
Zhang, Ziyu
Li, Li
Gao, Yang
Xiao, Xiaoxiong
Ji, Liyan
Zhou, Zhipeng
Jiang, Juan
Liu, Shiqing
An, Jian
Deng, Pengbo
Du, Nannan
Li, Pansong
Xia, Xuefeng
Hu, Chengping
Li, Min
CELLULAR ONCOLOGY, 2024, 47 (02) : 447 - 461
[44] Circulating tumor DNA in early-stage NSCLC: A lung TRACERx study
Abbosh, Christopher
CLINICAL CANCER RESEARCH, 2018, 24 (17)
[45] Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
Allibhai, Z.
Cho, B. C. J.
Taremi, M.
Atallah, S.
Hope, A.
Hwang, D.
Keshavjee, S.
Tsao, M.
Yasufuku, K.
Kim, S-W.
Bezjak, A.
EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (04) : 1039 - 1042
[46] Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC
Schmid-Bindert, G.
Chemaissani, A.
Fischer, J. R.
Schuette, W.
Mazieres, J.
Vinolas, N.
Wolf, M.
Vaury, A. Thareau
Leschinger, M.
Reck, M.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[47] Effects of perioperative blood transfusion on prognosis in early-stage cervical cancer
Samuel S. Lentz
Brent J. Shelton
Nancy J. Toy
Annals of Surgical Oncology, 1998, 5 : 216 - 219
[48] Effects of perioperative blood transfusion on prognosis in early-stage cervical cancer
Lentz, SS
Shelton, BH
Toy, NJ
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (03) : 216 - 219
[49] Tailoring chemoimmunotherapy de-escalation in early-stage triple-negative breast cancer
Goncalves, Anthony
de Nonneville, Alexandre
LANCET ONCOLOGY, 2025, 26 (03): : 273 - 274
[50] Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer NSCLC)
Spicer, J. D.
Gao, S.
Liberman, M.
Kato, T.
Tsuboi, M.
Lee, S. H.
Chen, K. N.
Dooms, C.
Majem, M.
Eigendorff, E.
Martinengo, G.
Bylicki, O.
Garassino, M. C.
Abreu, D. Rodriguez
Chaft, J.
Novello, S.
Yang, J.
Keller, S. M.
Samkari, A.
Wakelee, H.
ANNALS OF ONCOLOGY, 2023, 34 : S1297 - S1298

← 1 2 3 4 5 →